Vote for New Officers and Board of Directors

Submit Your Ballot by March 24

Now is the time to select ASE’s 2024 Slate of Officers and DirectorsUse this ballot to vote for the person nominated or write-in a nominee in the blank space provided. You can only vote for one person for each position, and any write-in nominees must be active ASE members. Your ballot must be received by March 24, 2024.

The new officers and directors will be introduced at the 35th ASE Scientific Sessions during the State of ASE Presidential Address on Saturday, June 15. This session is open to all Scientific Sessions registrants and will be streamed live for virtual attendees.

Congratulations to ASE’s Newest FASE!

In February, ASE welcomed 37 distinguished Fellows of the American Society of Echocardiography (FASE) recipients! These members exemplify excellence in the field of cardiovascular ultrasound through education, research, leadership, and volunteerism. They are ambassadors for ASE and recognized experts in their field. Join us in congratulating the newest FASE recipients

  • Amanda M. Ball, PharmD, BCPS, BCCP, FASE
  • Leighton Brady, FASE
  • Nadine Deacy, BS, RDCS, RVT, FASE
  • Mehran Ebadi-Tehrani, MD, FASE
  • Benjamin Gerhardy, PhD, FASE
  • Carson Homuth, RDCS, BS, FASE
  • Olusegun Oladele Olusanya, MD, FASE
  • Michekka C. Robinson, MBA, ACS, RDCS, FASE
  • Shubha Deep Roy, MD, FACC, FASE, FSCAI
  • Madhava T. Pally, MD, FASE
  • Justin Nadeem Tawil, MD, FASE
  • Kacy Taylor, MAH, RDCS, FASE
  • Nathan Tehrani, MD, FASE
  • Gabriel Altit, MD, MSc, FRCPC, FAAP, FASE
  • Jennifer Chen, MD, FASE
  • Oung Savly, MD, FASE
  • Jacob Elliott Schaff, MD, FASE
  • Xiu Tang, B.Sc, ACS, RDCS, FASE
  • Bianca Judy Coelho, FASE
  • Katharine Marie Belfrage, BS, RDCS, FASE
  • Dayana S. Haro, BS, FASE
  • Mitalee Patel, BS, RVT, RDCS, RDMS, FASE
  • Divyanshu Mohananey, MD, FASE
  • Wendy Tsang, MD, FASE
  • Joel Dykstra, FASE
  • Arif Albulushi, MD, FASE
  • Josheau Scott Doucet, RDCS (AE,FE,PE), FASE
  • Emma Bowcokc, MBBS, FASE
  • Sean R. McMahon, MD, FASE
  • Nasim Dana, BS, RCS, FASE
  • Neda Dianati Maleki, MD, MSc, FACC, FASE
  • James Michael Hodovan, PhD, RDCS, (AE,PE)
  • Candice S. Vacher, FASE
  • Danielle Gravlin, RDCS, FASE
  • Muhammad Waheed Raja, MBBS, FASE
  • Reinaldo Luis Pineiro, RCS, FASE
  • Jamel Peter Ortoleva, MD, FASE

A complete list of FASE members can be found at SeeMyHeart.org. To apply for FASE, or learn more, visit ASEcho.org/FASE. The next deadline to apply is April 1, 2024.

March on with a New Issue of JASE

The March issue of JASE is now online with much to showcase including a variety of clinical investigations ranging from safety of ultrasound enhancement agents, noninvasive testing for coronary heart disease, Doppler in valvular heart disease, 3D TEE after transcatheter mitral valve repair and outcome, septal perforator flow in HCM, and LV function in children with chronic kidney disease. A handful of editorials and letters to the editor accompany two brief research communications to round out this issue.

Dr. Pellikka’s editorial outlines the artificial intelligence content of particular interest to JASE for authors interested in submitting on this topic. Finally, Dr. Eidem’s President’s Message highlights congenital heart disease and ASE’s efforts to bring education and awareness to this important patient population during his presidency. Be sure to check out March’s Author Spotlight that features Mays T. Ali, MD, and Jeremy J. Thaden, MD, FASE, discussing their recent paper on adverse drug reactions to ultrasound enhancement agents.

Learn more here about the March issue and read what author Idan Roifman, MD, MSc, had to say about highlighted paper, “Comparing Costs of Noninvasive Cardiac Diagnostic Tests—a Population-Based Study.”

ASE 2024 Schedule at a Glance is Now Online!

The countdown to ASE’s 35th Annual Scientific Sessions has officially started! In just 100 days, the premier cardiovascular ultrasound event of the year will begin, and now is the time to make your plans to attend.

Download the Schedule at a Glance, which offers a first look at all sessions and times available during the conference. The new format this year will focus on short cases with panel discussions, more audience participation, and less didactic presentations. We can’t wait for you to experience this new way of learning June 14-16 in Portland, OregonRegister and reserve your hotel room early to save.

March on With a New Issue of JASE

The March issue of JASE includes, “Comparing Costs of Noninvasive Cardiac Diagnostic Tests—a Population-Based Study.” Author Idan Roifman, MD, MSc, remarks, “In a large population-based cohort consisting of >2 million people from Ontario, Canada who were evaluated for chest pain, we report that receipt of any non-invasive test (NIT) for the diagnosis of coronary artery disease was associated with a 12% reduction in downstream costs when compared to no testing. Graded exercise stress testing (GXT) and stress echocardiography were associated with the least downstream costs (approximately 20% reductions), whereas CCTA and MPI were associated with the highest relative costs (approximately 30% and 25% increased costs, respectively). Our findings are important from a health policy perspective for the following reasons. First, we demonstrated that receipt of any NIT was associated with reductions in downstream costs when compared to no testing despite the added initial costs of the test itself. This is significant as it indicates that the initial cost of testing is more than offset by downstream healthcare cost savings. Second, given that stress imaging and anatomical testing have been demonstrated to be similar in terms of their related downstream clinical outcomes, our results reporting that stress echocardiography is the least expensive modality are important, as they may lead to prioritization of this test. This is especially important in healthcare systems that do not require pre-approval for stress echocardiography, but may require it for other types of NIT, such as many systems in the United States.”

This issue includes numerous clinical investigations reporting on safety of ultrasound enhancement agents, noninvasive testing for coronary heart disease, Doppler use in valvular heart disease, 3D TEE after transcatheter mitral valve repair and outcome, septal perforator flow in HCM, and LV function in children with chronic kidney disease. Don’t miss a Special Report on multimodality appropriate use criteria for the detection and risk assessment of chronic coronary disease. Additionally, there are two brief research communications—one explores low-dose application of ultrasound-enhancing agents without flush and the other reports on reproducibility of echocardiographic measures of aortic stenosis severity and its impact on severity grading. Five editorials accompany these reports, and a handful of letters to the editor on the topics of mitral regurgitation phenotype and moderate aortic stenosis conclude this issue.

With contributions from Rickey E. Carter, PhD, and David Ouyang, MD, FASE, Dr. Pellikka’s editorial outlines the artificial intelligence content of particular interest to JASE for authors interested in submitting on this topic. In accordance with International Congenital Heart Defects Awareness Day, Dr. Eidem’s President’s Message highlights congenital heart disease and ASE’s efforts to bring education and awareness to this important population during his presidency.

Be sure to check out March’s Author Spotlight to learn more from lead authors Mays T. Ali, MD, and Jeremy J. Thaden, MD, FASE, as they discuss their recent paper, Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice. Please see the March ASE Education Calendar for a listing of educational opportunities far and wide.

Upcoming ASE Webinar: March 12

Register Now

Register now to attend ASE’s Women Leading in Echocardiography Laboratories: Challenges and Solutions webinar, taking place March 12, 7:00 – 8:00 PM ET. An expert panel of accomplished women leaders in echocardiography will share their success stories and discuss the specific challenges women encounter in echocardiography laboratories, including gender bias, work-life balance, and professional development hurdles. Attendees will discuss and propose effective strategies for overcoming these challenges and focus on mentorship, skill development, supportive work environments, and diversity and inclusion.

Attend ASEF’s 15th Annual Research Awards Gala

Registration for the Foundation’s 15th Annual Research Awards Gala is now OPEN! The ASE Foundation cordially invites you to attend our Crystal Gala, our premiere fundraising event honoring ASE’s 2024 award recipients and celebrating cardiovascular ultrasound research. Join us Saturday, June 15, at the Hyatt Regency Portland, for a wonderful evening of entertainment, dinner, and dancing.

Please note, Gala Registration options start with full tables and Supporter Level tickets first. Individual tickets at the Advocate, Benefactor, and Patron level may be available at a later date. Questions about the Gala? Please email Gala@ASEcho.org. Tickets will not be available on site. 

Read the February Echo Magazine

The February 2024 Echo magazine is now online! This issue contains interesting articles written by ASE members, including:

Each monthly issue includes articles or images related to cardiovascular ultrasound that are not research-related, as well as communications from the ASE President, Councils, Specialty Interest Groups, and the ASE education calendar. All active ASE members are eligible to submit articles to Echo magazineThe submission deadline for the May 2024 issue is March 15. Email Echo@ASEcho.org with questions.

Echo VOL | 13 Issue 2


View Issue Larger | Download (PDF)

Images from the Heart – Call for Photos

The ASE Foundation is accepting photograph submissions for the 2024 Images from the Heart photo exhibit. We are bringing back this beautiful display and we want your best shots! We are looking for pictures that you’ve taken from the heart that have meaning to you; they do not have to be medical in nature. Think of the phrases, “I left my heart in…” and “This has my heart” when considering what photos to submit. We invite you to share these memories (and tell us what they mean to you) for our exhibit, to be held during the ASE 2024 Scientific Sessions in Portland, OR, June 14 – 16.

Entries will be accepted until April 19. Full submission details can be found here. Give us your best shot!